Payments to Acquire Property, Plant, and Equipment of Ambrx Biopharma Cayman, Inc. from 31 Dec 2019 to 31 Mar 2023

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Ambrx Biopharma Cayman, Inc. quarterly and annual Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2019 to 31 Mar 2023.
  • Ambrx Biopharma Cayman, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2023 was $0, a 100% decline year-over-year.
  • Ambrx Biopharma Cayman, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2022 was $1,054,000, a 46% decline from 2021.
  • Ambrx Biopharma Cayman, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2021 was $1,956,000, a 676% increase from 2020.
  • Ambrx Biopharma Cayman, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2020 was $252,000, a 425% increase from 2019.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)

Ambrx Biopharma Cayman, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2023 $0 -$774,000 -100% 01 Jan 2023 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q1 2022 $774,000 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1

Ambrx Biopharma Cayman, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2022 $1,054,000 -$902,000 -46% 01 Jan 2022 31 Dec 2022 10-K 30 Mar 2023 2022 FY
2021 $1,956,000 +$1,704,000 +676% 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
2020 $252,000 +$204,000 +425% 01 Jan 2020 31 Dec 2020 20-F 26 Apr 2022 2021 FY
2019 $48,000 01 Jan 2019 31 Dec 2019 20-F 26 Apr 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.